Work

Promoting Repigmentation after Epidermal-cell suspension grafting and preVENTing the loss of melanocytes using topical ruxolitinib for vitiligo in resistant areas (PREVENT): a prospective monocentric interventional double-blind study

Year: 2025

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: British Journal of Dermatology

DOI: 10.1093/bjd/ljaf143

Authors: Pierre-Michel Dugourd, Davide Guardoli, Eric Fontas, Stephany Marie-Luce, Thierry Passeron

Institutions: Université Côte d'Azur, Centre Hospitalier Universitaire de Nice, Inserm, Centre Méditerranéen de Médecine Moléculaire

Language: English

Topic: melanin and skin pigmentation

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409519847

FWCI: 1.674

Cites: 5

Cited by: 4

Related to: 10